Madariaga MunozMCVillegas EstevezFJimenez LopezAJ, et al.Evaluation of quality of life and satisfaction of patients with neuropathic pain and breakthrough pain: economic impact based on quality of life. Pain Res Treat2018; 2018: 5394021.
2.
LohreETKelpstadPBennettMI, et al. From “breakthrough” to “episodic” cancer pain? A European Association for Palliative Care research network expert Delphi survey toward a common terminology and classification of transient cancer pain exacerbations. J Pain Symptom Manage. 2016; 51: 1013–1019.
3.
WebberKDaviesANZeppetellaG, et al. Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients. J Pain Symptom Manage. 2014; 48: 619–631.
4.
MesaroliGCampbellFHundertA, et al.Development of a screening tool for pediatric neuropathic pain and complex regional pain syndrome: pediatric PainSCAN. Clin J Pain2021; 38(1): 15–22.
5.
YangJBauerBAWahner-RoedlerDL, et al.The modified WHO analgesic ladder: is it appropriate for chronic non-cancer pain?J Pain Res2020; 13: 411–417.
